Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.38 USD | -3.26% | -13.93% | -29.88% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 26.22 | 32.80 | 28.23 |
Spread/Res. | -18.46% | -34.82% | -24.26% |
Spread/Supp. | +6.79% | +6.79% | +2.99% |
Support | 20.02 | 20.02 | 20.76 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.